Fenofibrate in Ulcerative Colitis
Condition: Inflammatory Bowel Diseases Interventions: Drug: Mesalamine; Drug: Fenofibrate 160mg Sponsors: Tanta University; Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University; Hend El-Said Abo Mansour, Faculty of Pharmacy, Menoufia University; Monir Hussein Bahgat, Faculty of Medicine, Mansura University; Eman Maamoun Ali El-Khateeb, Lecturer of Clinical Pharmacy, Faculty of Ph armacy, Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2023 Category: Research Source Type: clinical trials
Fenofibrate in Ulcerative Colitis
Condition: Inflammatory Bowel Diseases Interventions: Drug: Mesalamine; Drug: Fenofibrate 160mg Sponsors: Tanta University; Eman Ibrahim Elberri, Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University; Hend El-Said Abo Mansour, Biochemistry Department, Faculty of Pharmacy, Menoufia University; Monir Hussein Bahgat, Internal Medicine Department (Gastroenterology and Hepatology) , Faculty of Medicine, Mansura University; Eman Maamoun Ali El-Khateeb, Lecturer of Clinical Pharmacy, Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2023 Category: Research Source Type: clinical trials
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
Condition: Primary Biliary Cholangitis Interventions: Drug: Placebo Combined With Ursodeoxycholic Acid; Drug: Fenofibrate Combined With Ursodeoxycholic Acid Sponsor: Xijing Hospital of Digestive Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2023 Category: Research Source Type: clinical trials